content

RDIF and Virchow Biotech partner for production of Sputnik V vaccine in India

The Russian Direct Investment Fund (RDIF, Russiaโ€™s sovereign wealth fund), and Virchow Biotech Private Limited (part of the Virchow Group), one of the leading...

Boston Pharmaceuticals Enters into Unique Multi-Year Out-License and Option Agreement with GSK

Boston Pharmaceuticals announced a pioneering three-year out-license and option agreement with GlaxoSmithKline PLC. Boston Pharmaceuticals will become a preferred GSK partner for select pre-phase...

CanSino’s Covid-19 vaccine receives approval in Hungary for emergency use

The Hungarian National Institute of Pharmacy and Nutrition has granted approval for the emergency use of Chinese company CanSino Biologicsโ€™ Covid-19 vaccine. Named Convidecia, the...

US FDA approves Janssen’s PONVORY for relapsing multiple sclerosis

The US FDA has approved the Janssen Pharmaceutical Companies of Johnson & Johnsonโ€™s (JNJ) PONVORY (ponesimod) for treating adults with relapsing forms of multiple...

Fujifilm to Build the Largest Cell Culture Biopharmaceutical CDMO Facility in North America

FUJIFILM Corporation has announced the selection of Holly Springs, North Carolina as the location for its new large-scale cell culture production site in the...

Catalent Expands Partnership with Johnson to Significantly Increase Capacity for Sterile Manufacturing and Packaging of COVID-19 Vaccine in Italy

Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...

Gilead and Novo Nordisk Expand NASH Clinical Collaboration

Gilead Sciences, Inc. and Novo Nordisk A/S announced that the companies have expanded their clinical collaboration in non-alcoholic steatohepatitis (NASH). The companies will conduct a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read